Herkinorin negatively regulates NLRP3 inflammasome to alleviate neuronal ischemic injury through activating Mu opioid receptor and inhibiting the NF-kappa B pathway
机构:[1]Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China临床科室麻醉科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Department of Neurobiology and Center of Stroke, School of Basic Medical Science, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China
Herkinorin is a novel opioid receptor agonist. Activation of opioid receptors, a member of G protein coupled receptors (GPCRs), may play an important role in Herkinorin neuroprotection. GPCRs may modulate NOD-like receptor protein 3 (NLRP3)-mediated inflammatory responses in the mechanisms of inflammation-associated disease and pathological processes. In this study, we investigated the effects of Herkinorin on NLRP3 and the underlying receptor and molecular mechanisms in oxygen-glucose deprivation/reperfusion (OGD/R)-treated rat cortex neurons. First, Western blot analysis showed that Herkinorin can inhibit the activation of NLRP3 and Caspase-1, decrease the expression of interleukin (IL)-1 beta, and decrease the secretion of IL-6 and tumour necrosis factor alpha detected by enzyme-linked immunosorbent assay in OGD/R-treated neurons. Then we found that Herkinorin downregulated NLRP3 levels by inhibiting the activation of nuclear factor kappa B (NF-kappa B) pathway, reducing the phosphorylation level of p65 and I kappa B alpha in OGD/R-treated neurons (p < .05 or .01, n = 3 per group). Instead, both the mu opioid receptor (MOR) inhibitor, beta-funaltrexamine, and MOR knockdown reversed the effects of Herkinorin on NLRP3 (p < .05 or .01, n = 3 per group). Further, we found that the level of beta-arrestin2 decreased in the cell membrane and increased in the cytoplasm after Herkinorin pretreatment in OGD/R-treated neurons. In co-immunoprecipitation experiments, Herkinorin increased the binding of I kappa B alpha with beta-arrestin2, decreased the ubiquitination level of I kappa B alpha, and beta-arrestin2 knockdown reversed the effects of Herkinorin on I kappa B alpha in OGD/R-treated neurons (p < .05 or .01, n = 3 per group). Our data demonstrated that Herkinorin negatively regulated NLRP3 inflammasome to alleviate neuronal ischemic injury through inhibiting NF-kappa B pathway mediated primarily by MOR activation. Inhibition of the NF-kappa B pathway by Herkinorin may be achieved by decreasing the ubiquitination level of I kappa B alpha, in which beta-arrestin2 may play an important role.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301065]
第一作者机构:[1]Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China[2]Department of Neurobiology and Center of Stroke, School of Basic Medical Science, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China[*1]Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, #1 Dongjiaominxiang, Dongcheng District, Beijing 100730, China.[*2]Department of Neurobiology, Capital Medical University, #10 You An Men Wai Xi Tou Tiao, Beijing 100069, China.
推荐引用方式(GB/T 7714):
Cui Xu,Xu Xin,Ju Zhihai,et al.Herkinorin negatively regulates NLRP3 inflammasome to alleviate neuronal ischemic injury through activating Mu opioid receptor and inhibiting the NF-kappa B pathway[J].JOURNAL OF CELLULAR BIOCHEMISTRY.2021,122(9):1085-1097.doi:10.1002/jcb.29929.
APA:
Cui, Xu,Xu, Xin,Ju, Zhihai,Wang, Guyan,Xi, Chunhua&Li, Junfa.(2021).Herkinorin negatively regulates NLRP3 inflammasome to alleviate neuronal ischemic injury through activating Mu opioid receptor and inhibiting the NF-kappa B pathway.JOURNAL OF CELLULAR BIOCHEMISTRY,122,(9)
MLA:
Cui, Xu,et al."Herkinorin negatively regulates NLRP3 inflammasome to alleviate neuronal ischemic injury through activating Mu opioid receptor and inhibiting the NF-kappa B pathway".JOURNAL OF CELLULAR BIOCHEMISTRY 122..9(2021):1085-1097